Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 3,440 | 6,977 | 5,564 | 8,652 | 6,316 |
| Cost of Goods | 1,994 | 2,228 | 2,567 | 2,959 | 2,805 |
| Gross Profit | 1,446 | 4,749 | 2,997 | 5,693 | 3,511 |
| Operating Expenses | 10,961 | 22,458 | 13,685 | 14,618 | 15,287 |
| Operating Income | -8,521 | -17,481 | -10,121 | -7,966 | -10,971 |
| Interest Expense | 217 | 1,450 | 683 | 333 | 639 |
| Other Income | 103 | 1,247 | 187 | 16 | 494 |
| Pre-tax Income | -8,635 | -17,684 | -10,617 | -8,283 | -11,116 |
| Income Tax | 2 | 3 | 14 | 4 | 3 |
| Net Income Continuous | -8,637 | -17,687 | -10,631 | -8,287 | -11,119 |
| Net Income | $-8,637 | $-17,687 | $-10,631 | $-8,287 | $-11,119 |
| EPS Basic Total Ops | -5.52 | -11.06 | -6.65 | -5.04 | -6.75 |
| EPS Basic Continuous Ops | -5.17 | -10.62 | -6.38 | -5.01 | -6.75 |
| EPS Diluted Total Ops | -5.52 | -11.06 | -6.65 | -5.04 | -6.75 |
| EPS Diluted Continuous Ops | -5.17 | -10.62 | -6.38 | -5.01 | -6.75 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.23 | -0.37 | -0.28 | -0.37 |
| EBITDA(a) | $-7,292 | $-4,868 | $-8,784 | $-6,896 | $-9,735 |